Figure 5

AuROC analyses of the IgG glycoforms G0FN (A) and G0F (B) between the liver fibrosis and control groups, and of the S-HPX (C) between the fibrosis and cirrhosis groups.

AuROC analyses of the IgG glycoforms G0FN (A) and G0F (B) between the liver fibrosis and control groups, and of the S-HPX (C) between the fibrosis and cirrhosis groups.